AKESOgen Competitors and Similar CompaniesClear all
Aceragen's competitors and similar companies include Akebia Therapeutics.
 Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. | ||
Founding Date | Founding Date 1989 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Durham, US HQ | Locations Cambridge, US HQ |
Employees | Employees 3642% decrease | Employees 324187% increase |
Valuation ($) | Valuation ($) 3.2 m | Valuation ($) 359.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $4.9m (FY, 2022) | Revenue (est.) $236.2m (FY, 2025) |
Net income | Net income ($23.4m) (FY, 2022) | Net income ($5.3m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Akebia Therapeutics
HQ
Cambridge, US
Employees
324
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company